Navigation Links
China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS
Date:9/24/2009

an Blood Products Co., Ltd., is currently the largest non-state- owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. It sells its products to hospitals and other healthcare facilities in China.

Safe Harbor Statement

This release may contain certain "forward-looking statements" relating to the business of China Biologic Products, Inc. and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements," including statements regarding: the significance of the strategic research and development agreement with IBT on the business and operations of the Company; the ability of the Company to achieve its commercial objectives; the business strategy, plans and objectives of the Company and its subsidiaries, including the possibility that he strategic research and development agreement with IBT will advance the Company's strategy to bring new higher margin products to market; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Agro-Technology Holdings Reorganized
2. China Agro-Technology Holdings Announces Launch of Agricultural Biotech Website
3. Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
4. China Biologic Products to Attend at Susquehannas Third Annual Beijing Management Summit
5. China Biologic Products Appoints Director of Research and Development
6. China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit
7. Fauve Intertrade Signs Major Energy Contracts in China
8. China Biologic Products to Participate in the Rodman & Renshaw Annual Global Investment Conference
9. China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes
10. China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports
11. AOBOs Products Included in Chinas Essential Drug List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (MIPT and Russian Quantum Center at Skolkovo) and ... and the Institute of Physics in Bratislava, Slovakia) ... of particles passing through an amplifier and, conversely, ... are provided in an article published in the ... , Quantum entangled particles are considered to be ...
(Date:7/23/2014)... 2014 Last year, Formedix ... leading global provider of data management solutions for clinical ... leading-edge system for electronic data capture (EDC) and clinical ... and study execution tools added TrialMaster to its Transform ... version of Transform for TrialMaster, is being released this ...
(Date:7/23/2014)... July 23, 2014 DuPont Pioneer announced ... as vice president of Agricultural Biotechnology (ABT), effective July ... he served most recently as president, chief executive officer ... business leadership in the seed and crop protection industry ... Paul E. Schickler , president of DuPont Pioneer. “I ...
(Date:7/23/2014)... , July 23, 2014  Sofinnova Ventures, a ... announced the closing of Sofinnova Venture Partners IX, L.P. ... excess of the initial fund target of $425 million. ... successful biotechnology companies. Consistent with recent funds, SVP IX ... stage clinical programs, along with select investments in earlier ...
Breaking Biology Technology:Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Sofinnova Raises $500 Million Biotech Venture Fund 2
... WOBURN, Mass., April 7, 2011 The Center for Business ... to the American Red Cross in support of the relief ... employees made personal contributions to the fund while the organization ... the compassion and generosity CBI employees have displayed to help ...
... Fla. April 5, 2011 A new drug is ... an inherited predisposition to the disease. These patients with ... which can become locally invasive or metastatic, according to a ... at the 102nd annual meeting of the American Association for ...
... (Nasdaq: CEPH ) has scheduled its regular quarterly ... p.m. EDT on Tuesday, May 3, 2011. May 3, ... be distributed by PRNewswire4:50 p.m. EDT , To participate in ... 67208985:00 p.m. EDT , Conference call begins promptly. Simultaneous ...
Cached Biology Technology:The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan 2New drug is effective against the most common form of skin cancer 2
(Date:7/23/2014)... NY -- The potential for clinical use of ... therapeutic strategies has previously been hindered by the ... of tumors. The ability to use etoposide treatment ... treatment of heart disease, specifically acute myocardial infarction, ... Cells and Development , a peer-reviewed journal from ...
(Date:7/23/2014)... WELLESLEY, Massachusetts , July 23, 2014 ... reveals in its new report, GLOBAL MARKETS AND ... and related technologies is expected to grow to nearly ... growth rate (CAGR) of 10.1%. The image, flow, and ... CAGR.      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:7/23/2014)... This news release is available in German . ... use varying sensory modalities for orientation, some of which ... for example take the polarization pattern produced by sunlight ... researchers from the Max Planck Institute for Ornithology in ... colleagues from Israel that a night active mammal, the ...
Breaking Biology News(10 mins):Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 3Bats use the evening sky's polarization pattern for orientation 2
... Building Components (UHGBC), a program in the Gerald D. ... Expo. This event showcases the work of faculty-led research ... and sustainable technologies for the built environment. The ... the College of Architecture,s atrium. The event is free ...
... If Guinness World Records had a category for the largest ... just claimed it. They have designed and successfully ... manufacture the essential amino acid histidine. It is more than ... created by researchers at the University of Washington in 2003. ...
... study conducted by researchers at the Johns Hopkins Malaria ... of drug resistance in malaria-causing parasites taken from both ... human blood samples showed a high prevalence for pyrimethamine-resistance, ... used to treat malaria in the region. However, parasites ...
Cached Biology News:UH Green Building Components Expo showcasing eco-friendly projects 2Creation of the largest human-designed protein boosts protein engineering efforts 2Creation of the largest human-designed protein boosts protein engineering efforts 3Contrasting patterns of malaria drug resistance found between humans and mosquitoes 2
Request Info...
... blotted protein on PVDF membrane or with ... N-terminal sequence of proteins (5-20 residues) can ... HPLC or mono-and bidimensional SDS-PAGE, followed by ... the well known EDMAN degradation method. Pre-treatment ...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
ELF® 97 Immunohistochemistry Kit...
Biology Products: